Trulieve Cannabis (TCNNF) Other Non-Current Liabilities (2020 - 2026)

Trulieve Cannabis (TCNNF) recorded quarterly Other Non-Current Liabilities of $696.4 million in Q1 2026, up 5982.55% quarter-over-quarter from $11.4 million in Q4 2025, and down 1.6% on a YoY basis from $707.7 million in Q1 2025.

Trulieve Cannabis (TCNNF) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Trulieve Cannabis' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $696.4 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 1.6% year-over-year to $696.4 million; the TTM figure through Mar 2026 stood at $696.4 million (down 1.6% YoY), while the FY2025 annual figure was $11.4 million, up 131.11% from the prior year.
  • Other Non-Current Liabilities was $696.4 million for Q1 2026 at Trulieve Cannabis, up from $11.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $742.6 million in Q2 2025 to a low of $2.1 million in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $238.9 million across 5 years, with a median of $39.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities jumped 1694.75% in 2023, then tumbled 99.09% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $41.8 million in 2022, then surged by 1199.06% to $542.8 million in 2023, then sank by 99.09% to $5.0 million in 2024, then soared by 131.11% to $11.4 million in 2025, then surged by 5982.55% to $696.4 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $696.4 million (Q1 2026), $11.4 million (Q4 2025), and $11.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Trulieve Cannabis - - 170.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 696.39 Mn
Dec 31, 2025 11.45 Mn
Sep 30, 2025 11.77 Mn
Jun 30, 2025 742.65 Mn
Mar 31, 2025 707.72 Mn
Dec 31, 2024 4.95 Mn
Sep 30, 2024 6.51 Mn
Jun 30, 2024 333.10 Mn
Mar 31, 2024 579.80 Mn
Dec 31, 2023 542.76 Mn
Sep 30, 2023 86.44 Mn
Mar 31, 2023 37.24 Mn
Dec 31, 2022 41.78 Mn
Sep 30, 2022 8.62 Mn
Jun 30, 2022 9.16 Mn
Mar 31, 2022 2.08 Mn
Dec 31, 2021 6.67 Mn
Sep 30, 2021 6.44 Mn
Jun 30, 2021 42.69 Mn
Mar 31, 2021 44.43 Mn